Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia

Haematologica

Volumn 98, Issue 4, 2013, Pages 649-654

  Nguyen Khac, Florence ^a   Lambert, Jerome ^b   Chapiro, Elise ^a   Grelier, Aurore ^a   Mould, Sarah ^c   Barin, Carole ^d   Daudignon, Agnes ^e   Gachard, Nathalie ^f   Struski, Stéphanie ^g   Henry, Catherine ^h   Penther, Dominique ⁱ   Mossafa, Hossein ^j   Andrieux, Joris ^k   Eclache, Virginie ^l   Bilhou Nabera, Chrystèle ^m   Luquet, Isabelle ⁿ   Terre, Christine ^o   Baranger, Laurence ^p   Mugneret, Francine ^q   Chiesa, Jean ^r   Mozziconacci, Marie Joelle ^s   Callet Bauchu, Evelyne ^t   Veronese, Lauren ^u   Blons, Hélène ^v   Owen, Roger ^w   Lejeune, Julie ^b   Chevret, Sylvie ^b   Merle Beral, Hélène ^a   Leblond, Véronique ^a   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^d CHU BRETONNEAU   (France)

^e Service d'Hématologie Immunologie Cytogénétique   (France)

^f DUPUYTREN UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h Service d'urologie Université et hôpital de Rennes   (France)

ⁱ CENTRE HENRI BECQUEREL   (France)

^j LABORATOIRE CERBA   (France)

^k LILLE UNIVERSITY HOSPITAL   (France)

^l AVICENNE HOSPITAL   (France)

^m BICÊTRE HOSPITAL   (France)

ⁿ SERVICE DE DERMATOLOGIE   (France)

^o Service de Biologie   (France)

^p Hôpital d'Angers   (France)

^q Hôpital de Dijon   (France)

^r DEPARTMENT OF NEUROLOGY   (France)

^s INSTITUT PAOLI CALMETTES   (France)

^t CENTRE HOSPITALIER LYON SUD   (France)

^u Laboratoire de Cytogénétique   (France)

^v HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^w ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; FLUDARABINE; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME 18; CHROMOSOME 4; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 13Q; CHROMOSOME DELETION 6Q; CONTROLLED STUDY; CYTOGENETICS; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; HUMAN; IMMUNOPHENOTYPING; JACOBSEN SYNDROME; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRISOMY; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHLORAMBUCIL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; KARYOTYPE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TRISOMY; VIDARABINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 84875653870     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.070458     Document Type: Article

References (30)

1. Ocio EM, Schop RF, Gonzalez B, Van Wier SA, Hernandez-Rivas JM, Gutierrez NC, et al. 6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis. Br J Haematol. 2007;136(1):80-6.
2. Chang H, Qi C, Trieu Y, Jiang A, Young KH, Chesney A, et al. Prognostic relevance of 6q deletion in Waldenstrom's macroglobulinemia: a multicenter study. Clin Lymphoma Myeloma. 2009;9(1):36-8.
3. Terre C, Nguyen-Khac F, Barin C, Mozziconacci MJ, Eclache V, Leonard C, et al. Trisomy 4, a new chromosomal abnormality in Waldenstrom's macroglobulinemia: a study of 39 cases. Leukemia. 2006;20(9):1634-6.
4. Schop RF, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA, et al. Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at the time of disease progression. Cancer Genet Cytogenet. 2002;132(1):55-60.
5. Chang H, Samiee S, Li D, Patterson B, Chen CI, Stewart AK. Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom's macroglobulinemia: a single center study of 22 cases. Leukemia. 2004;18(6):1160-2.
6. Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH, Valdez R, et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia. Cancer Res. 2009;69(8):3579-88.
7. Leblond V, Lejeune J, Tournilhac O, Morel P, Dilhuydy MS, Dartigeas C, et al. International phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders: results in 414 patients on behalf of FCG CLL/ WM, GOELAMS, GELA, NCRI, ALLG. ASH Annual Meeting Abstracts. 2011;118(21):776.
8. Le Garff-Tavernier M, Blons H, Nguyen-Khac F, Pannetier M, Brissard M, Gueguen S, et al. Functional assessment of p53 in chronic lymphocytic leukemia. Blood Cancer J. 2011;1(2):e5.
9. Kaplan E, Meier P. Nonparametric Estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-81.
10. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. Journal of the Royal Statistical Society Series A (General). 1972;135(2):185-207.
11. Morel P, Duhamel A, Gobbi P, Dimopoulos MA, Dhodapkar MV, McCoy J, et al. International prognostic scoring system for Waldenstrom macroglobulinemia. Blood. 2009;113(18):4163-70.
12. Dimopoulos M, Gika D, Zervas K, Kyrtsonis M, Symeonidis A, Anagnostopoulos A, et al. The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia. Leuk Lymphoma. 2004;45(9):1809-13.
13. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009:523-31.
14. Letestu R, Levy V, Eclache V, Baran-Marszak F, Vaur D, Naguib D, et al. Prognosis of Binet stage A chronic lymphocytic leukemia patients: the strength of routine parameters. Blood. 2010;116(22):4588-90.
15. Sutton L, Chevret S, Tournilhac O, Divine M, Leblond V, Corront B, et al. Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC. Blood. 2011;117(23):6109-19.
16. Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23 (12):2210-21.
17. Callet-Bauchu E, Baseggio L, Felman P, Traverse-Glehen A, Berger F, Morel D, et al. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. Leukemia. 2005;19(10):1818-23.
18. Salido M, Baro C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E, et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood. 2010;116(9):1479-88.
19. Schop RF, Kuehl WM, Van Wier SA, Ahmann GJ, Price-Troska T, Bailey RJ, et al. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood. 2002;100(8):2996-3001.
20. Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood. 2006;107(2):742-51.
21. Dicker F, Schnittger S, Haferlach T, Kern W, Schoch C. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood. 2006;108(9):3152-60.
22. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910-6.
23. Gutierrez NC, Ocio EM, de Las Rivas J, Maiso P, Delgado M, Ferminan E, et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia. 2007;21(3):541-9.
24. Schop RF, Van Wier SA, Xu R, Ghobrial I, Ahmann GJ, Greipp PR, et al. 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet. 2006;169(2):150-3.
25. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99(24):15524-9.
26. Dohner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 1997;89(7):2516-22.
27. Zenz T, Krober A, Scherer K, Habe S, Buhler A, Benner A, et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood. 2008;112(8): 3322-9.
28. Lode L, Eveillard M, Trichet V, Soussi T, Wuilleme S, Richebourg S, et al. Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma. Haematologica. 2010;95(11):1973-6.
29. Hodge LS, Novak AJ, Grote DM, Braggio E, Ketterling RP, Manske MK, et al. Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1. Blood. 2011;117(19):e190-7.
30. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol. 1996;92(2):382-8.